Back to search results

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Abroad (travel likely)Recruiting

Conditions

Glioblastoma, IDH-Wildtype · WHO Grade 4 Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Study coordinator (Yazmeen Nims) · 480-342-2906
    Contact: Principal Investigator (Bernard Bendok, MD)

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Study coordinator (General Clinical Studies Unit) · 904-953-2255
    Contact: Principal Investigator (Alfredo Quinones-Hinojisa, MD)

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Gelareh Zadeh, MD, PhD)
Study leads

  • Gelareh Zadeh, MD, PhD

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)